We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+452.52%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,181
Increased
3,621
Reduced
5,174
Closed
1,161

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.21%
3 Healthcare 6.43%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
5476
Castle Biosciences
CSTL
$905M
$173K ﹤0.01%
3,849
-6,549
-63% -$271K
DHIL
5477
DELISTED
Diamond Hill
DHIL
$173K ﹤0.01%
921
-979
-52% -$182K
EIC
5478
Eagle Point Income Co
EIC
$233M
$173K ﹤0.01%
10,305
-1,784
-15% -$30.1K
GFL icon
5479
GFL Environmental
GFL
$15.1B
$173K ﹤0.01%
5,327
-610
-10% -$19.1K
MGF
5480
Aberdeen Government Markets Income Fund
MGF
$92.6M
$173K ﹤0.01%
45,769
-56,252
-55% -$223K
OCUL icon
5481
Ocular Therapeutix
OCUL
$2.2B
$173K ﹤0.01%
34,884
-60,006
-63% -$333K
MYE icon
5482
Myers Industries
MYE
$1.24B
$172K ﹤0.01%
7,952
-7,921
-50% -$145K
AGQ icon
5483
ProShares Ultra Silver
AGQ
$1.43B
$171K ﹤0.01%
4,444
+2,428
+120% +$89.1K
BSRR icon
5484
Sierra Bancorp
BSRR
$532M
$171K ﹤0.01%
6,828
-3
-0% -$80
CVY icon
5485
Invesco Zacks Multi-Asset Income ETF
CVY
$125M
$171K ﹤0.01%
7,147
+509
+8% +$12.4K
FPAY
5486
DELISTED
FlexShopper
FPAY
$171K ﹤0.01%
100,000
HLAH
5487
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$171K ﹤0.01%
17,453
+2,935
+20% +$28.7K
DCBO
5488
Docebo
DCBO
$584M
$170K ﹤0.01%
3,279
-3,360
-51% -$173K
DRD
5489
DRDGold
DRD
$2.1B
$170K ﹤0.01%
18,116
-2,522
-12% -$22.4K
MRSH
5490
PUT
Marsh
MRSH
$89.6B
$170K ﹤0.01%
1,000
-500
-33% -$78.8K
OGCP
5491
Empire State Realty Series 60
OGCP
$1.27B
$170K ﹤0.01%
17,952
-6,006
-25% -$56.4K
FRG
5492
DELISTED
Franchise Group, Inc.
FRG
$170K ﹤0.01%
4,106
-12,596
-75% -$583K
JCICU
5493
DELISTED
Jack Creek Investment Corp. Units
JCICU
$169K ﹤0.01%
17,171
+1,041
+6% +$10.3K
PLBC icon
5494
Plumas Bancorp
PLBC
$439M
$168K ﹤0.01%
4,393
+793
+22% +$29.9K
RILY icon
5495
BRC Group Holdings
RILY
$299M
$168K ﹤0.01%
2,403
+1,807
+303% +$122K
VHAQ.U
5496
DELISTED
Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
$168K ﹤0.01%
18,257
-1,171
-6% -$12.1K
CVET
5497
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
$168K ﹤0.01%
10,000
-1,600
-14% -$28K
THER
5498
DELISTED
THERATECHNOLOGIES INC COM
THER
$168K ﹤0.01%
68,460
-13,004
-16% -$31.9K
ASXC
5499
DELISTED
Asensus Surgical, Inc.
ASXC
$167K ﹤0.01%
266,174
-14,101
-5% -$10.9K
DDF
5500
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
$167K ﹤0.01%
15,402
-1,933
-11% -$21.2K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.